Suchergebnisse - "Kagan, Amanda B"

PubPharm (11)

1

DNA methyltransferase inhibitor exposure-response : Challenges and opportunities

enthalten in: Clinical and translational science | 2023

von Kagan, A. | Garrison, D. | Anders, N. | +4

2

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kagan, A. | Moses, B. | Lapidus, R. | +6

3

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kagan, A. | Moses, B. | Lapidus, R. | +6

4

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kagan, A. | Moses, B. | Lapidus, R. | +6

5

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kagan, A. | Moses, B. | Lapidus, R. | +6

6

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Shafer, D. | Kagan, A. | Rudek, M. | +9

7

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Shafer, D. | Kagan, A. | Rudek, M. | +9

8

DNA methyltransferase inhibitor exposure–response : Challenges and opportunities

enthalten in: Clinical and Translational Science | 2023

von Kagan, A. | Garrison, D. | Anders, N. | +4

9

Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry

enthalten in: Biomedical chromatography : BMC | 2022

von Kagan, A. | Anders, N. | Hemingway, A. | +6

10

Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography–tandem mass spectrometry

enthalten in: Biomedical Chromatography | 2022

von Kagan, A. | Anders, N. | Hemingway, A. | +6